APO Research
Talk to an analyst

APO RESEARCH · REPORT

Transforming Growth Factor Beta 1

Transforming growth factor beta 1 or TGF-β1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-β1 is encoded by the TGFB1 gene

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Transforming growth factor beta 1 or TGF-β1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-β1 is encoded by the TGFB1 gene

Selected research

Market Analysis & Forecast

Global Transforming Growth Factor Beta 1 Market Analysis and Forecast 2026-2032

21 December 2025194 pages

Choose your research edition.

Industry ResearchTransforming Growth Factor Beta 1 Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Transforming Growth Factor Beta 1 Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Transforming Growth Factor Beta 1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Transforming Growth Factor Beta 1 Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Transforming Growth Factor Beta 1 Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

Transforming growth factor beta 1 or TGF-β1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-β1 is encoded by the TGFB1 gene

North America is the largest Transforming Growth Factor Beta 1 market with about 69% market share. Europe is follower, accounting for about 16% market share.The key manufacturers are Roche, Shionogi Ltd, Acceleron Pharma Inc, Genzyme Corp, Isarna Therapeutics GmbH, Scholar Rock, Sirnaomics Inc, Eli Lilly and Co, Formation Biologics Inc, Novartis AG etc.

This report presents an overview of global market for Transforming Growth Factor Beta 1, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

Read the full market overview

This report researches the key producers of Transforming Growth Factor Beta 1, also provides the sales of main regions and countries. Of the upcoming market potential for Transforming Growth Factor Beta 1, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Transforming Growth Factor Beta 1 sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Transforming Growth Factor Beta 1 market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Transforming Growth Factor Beta 1 sales, projected growth trends, production technology, application and end-user industry.

Transforming Growth Factor Beta 1 Segment by Company

Roche

Shionogi Ltd

Acceleron Pharma Inc

Genzyme Corp

Isarna Therapeutics GmbH

Scholar Rock

Sirnaomics Inc

Eli Lilly and Co

Formation Biologics Inc

Novartis AG

Transforming Growth Factor Beta 1 Segment by Type

Pirfenidone

Galunisertib

Others

Transforming Growth Factor Beta 1 Segment by Application

IPF

Cancer

Others

Transforming Growth Factor Beta 1 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transforming Growth Factor Beta 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transforming Growth Factor Beta 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transforming Growth Factor Beta 1.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Transforming Growth Factor Beta 1 in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Transforming Growth Factor Beta 1 manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Transforming Growth Factor Beta 1 sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Transforming Growth Factor Beta 1 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Pirfenidone Major Manufacturers Table 3. Galunisertib Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global Transforming Growth Factor Beta 1 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. IPF Major Manufacturers Table 7. Cancer Major Manufacturers Table 8. Others Major Manufacturers Table 9. Transforming Growth Factor Beta 1 Industry Trends Table 10. Transforming Growth Factor Beta 1 Industry Drivers Table 11. Transforming Growth Factor Beta 1 Industry Opportunities and Challenges Table 12. Transforming Growth Factor Beta 1 Industry Restraints Table 13. Global Transforming Growth Factor Beta 1 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Transforming Growth Factor Beta 1 Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Transforming Growth Factor Beta 1 Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Transforming Growth Factor Beta 1 Revenue Market Share by Region (2021-2026) Table 17. Global Transforming Growth Factor Beta 1 Revenue Market Share by Region (2027-2032) Table 18. Global Transforming Growth Factor Beta 1 Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Transforming Growth Factor Beta 1 Sales by Region (2021-2026) & (K Units) Table 20. Global Transforming Growth Factor Beta 1 Sales by Region (2027-2032) & (K Units) Table 21. Global Transforming Growth Factor Beta 1 Sales Market Share by Region (2021-2026) Table 22. Global Transforming Growth Factor Beta 1 Sales Market Share by Region (2027-2032) Table 23. Global Transforming Growth Factor Beta 1 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Transforming Growth Factor Beta 1 Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Transforming Growth Factor Beta 1 Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Transforming Growth Factor Beta 1 Sales Market Share by Manufacturers (2021-2026) Table 27. Global Transforming Growth Factor Beta 1 Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 28. Global Transforming Growth Factor Beta 1 Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Transforming Growth Factor Beta 1 Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Transforming Growth Factor Beta 1 Manufacturers, Product Type & Application Table 31. Global Transforming Growth Factor Beta 1 Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Transforming Growth Factor Beta 1 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Transforming Growth Factor Beta 1 Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Transforming Growth Factor Beta 1 Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Transforming Growth Factor Beta 1 Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Transforming Growth Factor Beta 1 Revenue Market Share by Type (2021-2026) Table 38. Global Transforming Growth Factor Beta 1 Revenue Market Share by Type (2027-2032) Table 39. Global Transforming Growth Factor Beta 1 Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Transforming Growth Factor Beta 1 Sales by Type (2021-2026) & (K Units) Table 41. Global Transforming Growth Factor Beta 1 Sales by Type (2027-2032) & (K Units) Table 42. Global Transforming Growth Factor Beta 1 Sales Market Share by Type (2021-2026) Table 43. Global Transforming Growth Factor Beta 1 Sales Market Share by Type (2027-2032) Table 44. Global Transforming Growth Factor Beta 1 Price by Type (2021-2026) & (USD/Unit) Table 45. Global Transforming Growth Factor Beta 1 Price by Type (2027-2032) & (USD/Unit) Table 46. Global Transforming Growth Factor Beta 1 Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Transforming Growth Factor Beta 1 Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Transforming Growth Factor Beta 1 Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Transforming Growth Factor Beta 1 Revenue Market Share by Application (2021-2026) Table 50. Global Transforming Growth Factor Beta 1 Revenue Market Share by Application (2027-2032) Table 51. Global Transforming Growth Factor Beta 1 Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Transforming Growth Factor Beta 1 Sales by Application (2021-2026) & (K Units) Table 53. Global Transforming Growth Factor Beta 1 Sales by Application (2027-2032) & (K Units) Table 54. Global Transforming Growth Factor Beta 1 Sales Market Share by Application (2021-2026) Table 55. Global Transforming Growth Factor Beta 1 Sales Market Share by Application (2027-2032) Table 56. Global Transforming Growth Factor Beta 1 Price by Application (2021-2026) & (USD/Unit) Table 57. Global Transforming Growth Factor Beta 1 Price by Application (2027-2032) & (USD/Unit) Table 58. Roche Company Information Table 59. Roche Business Overview Table 60. Roche Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 61. Roche Transforming Growth Factor Beta 1 Product Portfolio Table 62. Roche Recent Development Table 63. Shionogi Ltd Company Information Table 64. Shionogi Ltd Business Overview Table 65. Shionogi Ltd Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 66. Shionogi Ltd Transforming Growth Factor Beta 1 Product Portfolio Table 67. Shionogi Ltd Recent Development Table 68. Acceleron Pharma Inc Company Information Table 69. Acceleron Pharma Inc Business Overview Table 70. Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 71. Acceleron Pharma Inc Transforming Growth Factor Beta 1 Product Portfolio Table 72. Acceleron Pharma Inc Recent Development Table 73. Genzyme Corp Company Information Table 74. Genzyme Corp Business Overview Table 75. Genzyme Corp Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 76. Genzyme Corp Transforming Growth Factor Beta 1 Product Portfolio Table 77. Genzyme Corp Recent Development Table 78. Isarna Therapeutics GmbH Company Information Table 79. Isarna Therapeutics GmbH Business Overview Table 80. Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 81. Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Product Portfolio Table 82. Isarna Therapeutics GmbH Recent Development Table 83. Scholar Rock Company Information Table 84. Scholar Rock Business Overview Table 85. Scholar Rock Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 86. Scholar Rock Transforming Growth Factor Beta 1 Product Portfolio Table 87. Scholar Rock Recent Development Table 88. Sirnaomics Inc Company Information Table 89. Sirnaomics Inc Business Overview Table 90. Sirnaomics Inc Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 91. Sirnaomics Inc Transforming Growth Factor Beta 1 Product Portfolio Table 92. Sirnaomics Inc Recent Development Table 93. Eli Lilly and Co Company Information Table 94. Eli Lilly and Co Business Overview Table 95. Eli Lilly and Co Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 96. Eli Lilly and Co Transforming Growth Factor Beta 1 Product Portfolio Table 97. Eli Lilly and Co Recent Development Table 98. Formation Biologics Inc Company Information Table 99. Formation Biologics Inc Business Overview Table 100. Formation Biologics Inc Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 101. Formation Biologics Inc Transforming Growth Factor Beta 1 Product Portfolio Table 102. Formation Biologics Inc Recent Development Table 103. Novartis AG Company Information Table 104. Novartis AG Business Overview Table 105. Novartis AG Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 106. Novartis AG Transforming Growth Factor Beta 1 Product Portfolio Table 107. Novartis AG Recent Development Table 108. North America Transforming Growth Factor Beta 1 Revenue by Type (2021-2026) & (US$ Million) Table 109. North America Transforming Growth Factor Beta 1 Revenue by Type (2027-2032) & (US$ Million) Table 110. North America Transforming Growth Factor Beta 1 Sales by Type (2021-2026) & (K Units) Table 111. North America Transforming Growth Factor Beta 1 Sales by Type (2027-2032) & (K Units) Table 112. North America Transforming Growth Factor Beta 1 Sales Price by Type (2021-2026) & (USD/Unit) Table 113. North America Transforming Growth Factor Beta 1 Sales Price by Type (2027-2032) & (USD/Unit) Table 114. North America Transforming Growth Factor Beta 1 Revenue by Application (2021-2026) & (US$ Million) Table 115. North America Transforming Growth Factor Beta 1 Revenue by Application (2027-2032) & (US$ Million) Table 116. North America Transforming Growth Factor Beta 1 Sales by Application (2021-2026) & (K Units) Table 117. North America Transforming Growth Factor Beta 1 Sales by Application (2027-2032) & (K Units) Table 118. North America Transforming Growth Factor Beta 1 Sales Price by Application (2021-2026) & (USD/Unit) Table 119. North America Transforming Growth Factor Beta 1 Sales Price by Application (2027-2032) & (USD/Unit) Table 120. North America Transforming Growth Factor Beta 1 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. North America Transforming Growth Factor Beta 1 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 122. North America Transforming Growth Factor Beta 1 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 123. North America Transforming Growth Factor Beta 1 Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 124. North America Transforming Growth Factor Beta 1 Sales by Country (2021-2026) & (K Units) Table 125. North America Transforming Growth Factor Beta 1 Sales by Country (2027-2032) & (K Units) Table 126. North America Transforming Growth Factor Beta 1 Sales Price by Country (2021-2026) & (USD/Unit) Table 127. North America Transforming Growth Factor Beta 1 Sales Price by Country (2027-2032) & (USD/Unit) Table 128. United States Transforming Growth Factor Beta 1 Revenue (2021-2032) & (US$ Million) Table 129. Canada Transforming Growth Factor Beta 1 Revenue (2021-2032) & (US$ Million) Table 130. Mexico Transforming Growth Factor Beta 1 Revenue (2021-2032) & (US$ Million) Table 131. Europe Transforming Growth Factor Beta 1 Revenue by Type (2021-2026) & (US$ Million) Table 132. Europe Transforming Growth Factor Beta 1 Revenue by Type (2027-2032) & (US$ Million) Table 133. Europe Transforming Growth Factor Beta 1 Sales by Type (2021-2026) & (K Units) Table 134. Europe Transforming Growth Factor Beta 1 Sales by Type (2027-2032) & (K Units) Table 135. Europe Transforming Growth Factor Beta 1 Sales Price by Type (2021-2026) & (USD/Unit) Table 136. Europe Transforming Growth Factor Beta 1 Sales Price by Type (2027-2032) & (USD/Unit) Table 137. Europe Transforming Growth Factor Beta 1 Revenue by Application (2021-2026) & (US$ Million) Table 138. Europe Transforming Growth Factor Beta 1 Revenue by Application (2027-2032) & (US$ Million) Table 139. Europe Transforming Growth Factor Beta 1 Sales by Application (2021-2026) & (K Units) Table 140. Europe Transforming Growth Factor Beta 1 Sales by Application (2027-2032) & (K Units) Table 141. Europe Transforming Growth Factor Beta 1 Sales Price by Application (2021-2026) & (USD/Unit) Table 142. Europe Transforming Growth Factor Beta 1 Sales Price by Application (2027-2032) & (USD/Unit) Table 143. Europe Transforming Growth Factor Beta 1 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. Europe Transforming Growth Factor Beta 1 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 145. Europe Transforming Growth Factor Beta 1 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 146. Europe Transforming Growth Factor Beta 1 Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 147. Europe Transforming Growth Factor Beta 1 Sales by Country (2021-2026) & (K Units) Table 148. Europe Transforming Growth Factor Beta 1 Sales by Country (2027-2032) & (K Units) Table 149. Europe Transforming Growth Factor Beta 1 Sales Price by Country (2021-2026) & (USD/Unit) Table 150. Europe Transforming Growth Factor Beta 1 Sales Price by Country (2027-2032) & (USD/Unit) Table 151. Germany Transforming Growth Factor Beta 1 Revenue (2021-2032) & (US$ Million) Table 152. France Transforming Growth Factor Beta 1 Revenue (2021-2032) & (US$ Million) Table 153. U.K. Transforming Growth Factor Beta 1 Revenue (2021-2032) & (US$ Million) Table 154. Italy Transforming Growth Factor Beta 1 Revenue (2021-2032) & (US$ Million) Table 155. Russia Transforming Growth Factor Beta 1 Revenue (2021-2032) & (US$ Million) Table 156. Spain Transforming Growth Factor Beta 1 Revenue (2021-2032) & (US$ Million) Table 157. Netherlands Transforming Growth Factor Beta 1 Revenue (2021-2032) & (US$ Million) Table 158. Switzerland Transforming Growth Factor Beta 1 Revenue (2021-2032) & (US$ Million) Table 159. Sweden Transforming Growth Factor Beta 1 Revenue (2021-2032) & (US$ Million) Table 160. Poland Transforming Growth Factor Beta 1 Revenue (2021-2032) & (US$ Million) Table 161. China Transforming Growth Factor Beta 1 Revenue by Type (2021-2026) & (US$ Million) Table 162. China Transforming Growth Factor Beta 1 Revenue by Type (2027-2032) & (US$ Million) Table 163. China Transforming Growth Factor Beta 1 Sales by Type (2021-2026) & (K Units) Table 164. China Transforming Growth Factor Beta 1 Sales by Type (2027-2032) & (K Units) Table 165. China Transforming Growth Factor Beta 1 Sales Price by Type (2021-2026) & (USD/Unit) Table 166. China Transforming Growth Factor Beta 1 Sales Price by Type (2027-2032) & (USD/Unit) Table 167. China Transforming Growth Factor Beta 1 Revenue by Application (2021-2026) & (US$ Million) Table 168. China Transforming Growth Factor Beta 1 Revenue by Application (2027-2032) & (US$ Million) Table 169. China Transforming Growth Factor Beta 1 Sales by Application (2021-2026) & (K Units) Table 170. China Transforming Growth Factor Beta 1 Sales by Application (2027-2032) & (K Units) Table 171. China Transforming Growth Factor Beta 1 Sales Price by Application (2021-2026) & (USD/Unit) Table 172. China Transforming Growth Factor Beta 1 Sales Price by Application (2027-2032) & (USD/Unit) Table 173. Asia Transforming Growth Factor Beta 1 Revenue by Type (2021-2026) & (US$ Million) Table 174. Asia Transforming Growth Factor Beta 1 Revenue by Type (2027-2032) & (US$ Million) Table 175. Asia Transforming Growth Factor Beta 1 Sales by Type (2021-2026) & (K Units) Table 176. Asia Transforming Growth Factor Beta 1 Sales by Type (2027-2032) & (K Units) Table 177. Asia Transforming Growth Factor Beta 1 Sales Price by Type (2021-2026) & (USD/Unit) Table 178. Asia Transforming Growth Factor Beta 1 Sales Price by Type (2027-2032) & (USD/Unit) Table 179. Asia Transforming Growth Factor Beta 1 Revenue by Application (2021-2026) & (US$ Million) Table 180. Asia Transforming Growth Factor Beta 1 Revenue by Application (2027-2032) & (US$ Million) Table 181. Asia Transforming Growth Factor Beta 1 Sales by Application (2021-2026) & (K Units) Table 182. Asia Transforming Growth Factor Beta 1 Sales by Application (2027-2032) & (K Units) Table 183. Asia Transforming Growth Factor Beta 1 Sales Price by Application (2021-2026) & (USD/Unit) Table 184. Asia Transforming Growth Factor Beta 1 Sales Price by Application (2027-2032) & (USD/Unit) Table 185. Asia Transforming Growth Factor Beta 1 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 186. Asia Transforming Growth Factor Beta 1 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 187. Asia Transforming Growth Factor Beta 1 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 188. Asia Transforming Growth Factor Beta 1 Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 189. Asia Transforming Growth Factor Beta 1 Sales by Country (2021-2026) & (K Units) Table 190. Asia Transforming Growth Factor Beta 1 Sales by Country (2027-2032) & (K Units) Table 191. Asia Transforming Growth Factor Beta 1 Sales Price by Country (2021-2026) & (USD/Unit) Table 192. Asia Transforming Growth Factor Beta 1 Sales Price by Country (2027-2032) & (USD/Unit) Table 193. Japan Transforming Growth Factor Beta 1 Revenue (2021-2032) & (US$ Million) Table 194. South Korea Transforming Growth Factor Beta 1 Revenue (2021-2032) & (US$ Million) Table 195. India Transforming Growth Factor Beta 1 Revenue (2021-2032) & (US$ Million) Table 196. Australia Transforming Growth Factor Beta 1 Revenue (2021-2032) & (US$ Million) Table 197. Taiwan Transforming Growth Factor Beta 1 Revenue (2021-2032) & (US$ Million) Table 198. Southeast Asia Transforming Growth Factor Beta 1 Revenue (2021-2032) & (US$ Million) Table 199. SAMEA Transforming Growth Factor Beta 1 Revenue by Type (2021-2026) & (US$ Million) Table 200. SAMEA Transforming Growth Factor Beta 1 Revenue by Type (2027-2032) & (US$ Million) Table 201. SAMEA Transforming Growth Factor Beta 1 Sales by Type (2021-2026) & (K Units) Table 202. SAMEA Transforming Growth Factor Beta 1 Sales by Type (2027-2032) & (K Units) Table 203. SAMEA Transforming Growth Factor Beta 1 Sales Price by Type (2021-2026) & (USD/Unit) Table 204. SAMEA Transforming Growth Factor Beta 1 Sales Price by Type (2027-2032) & (USD/Unit) Table 205. SAMEA Transforming Growth Factor Beta 1 Revenue by Application (2021-2026) & (US$ Million) Table 206. SAMEA Transforming Growth Factor Beta 1 Revenue by Application (2027-2032) & (US$ Million) Table 207. SAMEA Transforming Growth Factor Beta 1 Sales by Application (2021-2026) & (K Units) Table 208. SAMEA Transforming Growth Factor Beta 1 Sales by Application (2027-2032) & (K Units) Table 209. SAMEA Transforming Growth Factor Beta 1 Sales Price by Application (2021-2026) & (USD/Unit) Table 210. SAMEA Transforming Growth Factor Beta 1 Sales Price by Application (2027-2032) & (USD/Unit) Table 211. SAMEA Transforming Growth Factor Beta 1 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 212. SAMEA Transforming Growth Factor Beta 1 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 213. SAMEA Transforming Growth Factor Beta 1 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 214. SAMEA Transforming Growth Factor Beta 1 Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 215. SAMEA Transforming Growth Factor Beta 1 Sales by Country (2021-2026) & (K Units) Table 216. SAMEA Transforming Growth Factor Beta 1 Sales by Country (2027-2032) & (K Units) Table 217. SAMEA Transforming Growth Factor Beta 1 Sales Price by Country (2021-2026) & (USD/Unit) Table 218. SAMEA Transforming Growth Factor Beta 1 Sales Price by Country (2027-2032) & (USD/Unit) Table 219. Brazil Transforming Growth Factor Beta 1 Revenue (2021-2032) & (US$ Million) Table 220. Argentina Transforming Growth Factor Beta 1 Revenue (2021-2032) & (US$ Million) Table 221. Chile Transforming Growth Factor Beta 1 Revenue (2021-2032) & (US$ Million) Table 222. Colombia Transforming Growth Factor Beta 1 Revenue (2021-2032) & (US$ Million) Table 223. Peru Transforming Growth Factor Beta 1 Revenue (2021-2032) & (US$ Million) Table 224. Saudi Arabia Transforming Growth Factor Beta 1 Revenue (2021-2032) & (US$ Million) Table 225. Israel Transforming Growth Factor Beta 1 Revenue (2021-2032) & (US$ Million) Table 226. UAE Transforming Growth Factor Beta 1 Revenue (2021-2032) & (US$ Million) Table 227. Turkey Transforming Growth Factor Beta 1 Revenue (2021-2032) & (US$ Million) Table 228. Iran Transforming Growth Factor Beta 1 Revenue (2021-2032) & (US$ Million) Table 229. Egypt Transforming Growth Factor Beta 1 Revenue (2021-2032) & (US$ Million) Table 230. Key Raw Materials Table 231. Raw Materials Key Suppliers Table 232. Transforming Growth Factor Beta 1 Distributors List Table 233. Transforming Growth Factor Beta 1 Customers List Table 234. Research Programs/Design for This Report Table 235. Authors List of This Report Table 236. Secondary Sources Table 237. Primary Sources List of Figures Figure 1. Transforming Growth Factor Beta 1 Image Figure 2. Global Transforming Growth Factor Beta 1 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Transforming Growth Factor Beta 1 Market Size Share 2021 VS 2025 VS 2032 Figure 4. Pirfenidone Image Figure 5. Galunisertib Image Figure 6. Others Image Figure 7. Global Transforming Growth Factor Beta 1 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Transforming Growth Factor Beta 1 Market Size Share 2021 VS 2025 VS 2032 Figure 9. IPF Image Figure 10. Cancer Image Figure 11. Others Image Figure 12. Global Transforming Growth Factor Beta 1 Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Transforming Growth Factor Beta 1 Revenue (2021-2032) & (US$ Million) Figure 14. Global Transforming Growth Factor Beta 1 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Transforming Growth Factor Beta 1 Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Transforming Growth Factor Beta 1 Revenue Market Share by Region (2021-2032) Figure 17. Global Transforming Growth Factor Beta 1 Sales (2021-2032) & (K Units) Figure 18. Global Transforming Growth Factor Beta 1 Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Transforming Growth Factor Beta 1 Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Transforming Growth Factor Beta 1 Sales YoY (2021-2032) & (K Units) Figure 21. Europe Transforming Growth Factor Beta 1 Sales YoY (2021-2032) & (K Units) Figure 22. China Transforming Growth Factor Beta 1 Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Transforming Growth Factor Beta 1 Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Transforming Growth Factor Beta 1 Sales YoY (2021-2032) & (K Units) Figure 25. Global Transforming Growth Factor Beta 1 Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Transforming Growth Factor Beta 1 Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Transforming Growth Factor Beta 1 Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Transforming Growth Factor Beta 1 Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Transforming Growth Factor Beta 1 Revenue Market Share by Type (2021-2032) Figure 31. Global Transforming Growth Factor Beta 1 Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Transforming Growth Factor Beta 1 Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Transforming Growth Factor Beta 1 Sales Market Share by Type (2021-2032) Figure 34. Global Transforming Growth Factor Beta 1 Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Transforming Growth Factor Beta 1 Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Transforming Growth Factor Beta 1 Revenue Market Share by Application (2021-2032) Figure 37. Global Transforming Growth Factor Beta 1 Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Transforming Growth Factor Beta 1 Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Transforming Growth Factor Beta 1 Sales Market Share by Application (2021-2032) Figure 40. North America Transforming Growth Factor Beta 1 Revenue Share by Type (2021-2032) Figure 41. North America Transforming Growth Factor Beta 1 Sales Share by Type (2021-2032) Figure 42. North America Transforming Growth Factor Beta 1 Revenue Share by Application (2021-2032) Figure 43. North America Transforming Growth Factor Beta 1 Sales Share by Application (2021-2032) Figure 44. North America Transforming Growth Factor Beta 1 Revenue Share by Country (2021-2032) Figure 45. North America Transforming Growth Factor Beta 1 Sales Share by Country (2021-2032) Figure 46. Europe Transforming Growth Factor Beta 1 Revenue Share by Type (2021-2032) Figure 47. Europe Transforming Growth Factor Beta 1 Sales Share by Type (2021-2032) Figure 48. Europe Transforming Growth Factor Beta 1 Revenue Share by Application (2021-2032) Figure 49. Europe Transforming Growth Factor Beta 1 Sales Share by Application (2021-2032) Figure 50. Europe Transforming Growth Factor Beta 1 Revenue Share by Country (2021-2032) Figure 51. Europe Transforming Growth Factor Beta 1 Sales Share by Country (2021-2032) Figure 52. China Transforming Growth Factor Beta 1 Revenue Share by Type (2021-2032) Figure 53. China Transforming Growth Factor Beta 1 Sales Share by Type (2021-2032) Figure 54. China Transforming Growth Factor Beta 1 Revenue Share by Application (2021-2032) Figure 55. China Transforming Growth Factor Beta 1 Sales Share by Application (2021-2032) Figure 56. Asia Transforming Growth Factor Beta 1 Revenue Share by Type (2021-2032) Figure 57. Asia Transforming Growth Factor Beta 1 Sales Share by Type (2021-2032) Figure 58. Asia Transforming Growth Factor Beta 1 Revenue Share by Application (2021-2032) Figure 59. Asia Transforming Growth Factor Beta 1 Sales Share by Application (2021-2032) Figure 60. Asia Transforming Growth Factor Beta 1 Revenue Share by Country (2021-2032) Figure 61. Asia Transforming Growth Factor Beta 1 Sales Share by Country (2021-2032) Figure 62. SAMEA Transforming Growth Factor Beta 1 Revenue Share by Type (2021-2032) Figure 63. SAMEA Transforming Growth Factor Beta 1 Sales Share by Type (2021-2032) Figure 64. SAMEA Transforming Growth Factor Beta 1 Revenue Share by Application (2021-2032) Figure 65. SAMEA Transforming Growth Factor Beta 1 Sales Share by Application (2021-2032) Figure 66. SAMEA Transforming Growth Factor Beta 1 Revenue Share by Country (2021-2032) Figure 67. SAMEA Transforming Growth Factor Beta 1 Sales Share by Country (2021-2032) Figure 68. Transforming Growth Factor Beta 1 Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Transforming Growth Factor Beta 1 Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Pirfenidone
  • Galunisertib
  • Others
Applications
  • IPF
  • Cancer
  • Others
Companies covered
  • Roche
  • Shionogi Ltd
  • Acceleron Pharma Inc
  • Genzyme Corp
  • Isarna Therapeutics GmbH
  • Scholar Rock
  • Sirnaomics Inc
  • Eli Lilly and Co
  • Formation Biologics Inc
  • Novartis AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Transforming Growth Factor Beta 1 Market by Type
  3. 1.2.1 Global Transforming Growth Factor Beta 1 Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Pirfenidone
  5. 1.2.3 Galunisertib
  6. 1.2.4 Others
  7. 1.3 Transforming Growth Factor Beta 1 Market by Application
  8. 1.3.1 Global Transforming Growth Factor Beta 1 Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 IPF
  10. 1.3.3 Cancer
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Transforming Growth Factor Beta 1 Market Dynamics
  1. 2.1 Transforming Growth Factor Beta 1 Industry Trends
  2. 2.2 Transforming Growth Factor Beta 1 Industry Drivers
  3. 2.3 Transforming Growth Factor Beta 1 Industry Opportunities and Challenges
  4. 2.4 Transforming Growth Factor Beta 1 Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Transforming Growth Factor Beta 1 Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Transforming Growth Factor Beta 1 Revenue by Region
  3. 3.2.1 Global Transforming Growth Factor Beta 1 Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Transforming Growth Factor Beta 1 Revenue by Region (2021-2026)
  5. 3.2.3 Global Transforming Growth Factor Beta 1 Revenue by Region (2027-2032)
  6. 3.2.4 Global Transforming Growth Factor Beta 1 Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Transforming Growth Factor Beta 1 Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Transforming Growth Factor Beta 1 Sales by Region
  9. 3.4.1 Global Transforming Growth Factor Beta 1 Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Transforming Growth Factor Beta 1 Sales by Region (2021-2026)
  11. 3.4.3 Global Transforming Growth Factor Beta 1 Sales by Region (2027-2032)
  12. 3.4.4 Global Transforming Growth Factor Beta 1 Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Transforming Growth Factor Beta 1 Revenue by Manufacturers
  2. 4.1.1 Global Transforming Growth Factor Beta 1 Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Transforming Growth Factor Beta 1 Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Transforming Growth Factor Beta 1 Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Transforming Growth Factor Beta 1 Sales by Manufacturers
  6. 4.2.1 Global Transforming Growth Factor Beta 1 Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Transforming Growth Factor Beta 1 Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Transforming Growth Factor Beta 1 Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Transforming Growth Factor Beta 1 Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Transforming Growth Factor Beta 1 Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Transforming Growth Factor Beta 1 Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Transforming Growth Factor Beta 1 Manufacturers, Product Type & Application
  13. 4.7 Global Transforming Growth Factor Beta 1 Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Transforming Growth Factor Beta 1 Market CR5 and HHI
  16. 4.8.2 2025 Transforming Growth Factor Beta 1 Tier 1, Tier 2, and Tier 3
5 Transforming Growth Factor Beta 1 Market by Type
  1. 5.1 Global Transforming Growth Factor Beta 1 Revenue by Type
  2. 5.1.1 Global Transforming Growth Factor Beta 1 Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Transforming Growth Factor Beta 1 Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Transforming Growth Factor Beta 1 Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Transforming Growth Factor Beta 1 Sales by Type
  6. 5.2.1 Global Transforming Growth Factor Beta 1 Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Transforming Growth Factor Beta 1 Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Transforming Growth Factor Beta 1 Sales Market Share by Type (2021-2032)
  9. 5.3 Global Transforming Growth Factor Beta 1 Price by Type
6 Transforming Growth Factor Beta 1 Market by Application
  1. 6.1 Global Transforming Growth Factor Beta 1 Revenue by Application
  2. 6.1.1 Global Transforming Growth Factor Beta 1 Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Transforming Growth Factor Beta 1 Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Transforming Growth Factor Beta 1 Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Transforming Growth Factor Beta 1 Sales by Application
  6. 6.2.1 Global Transforming Growth Factor Beta 1 Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Transforming Growth Factor Beta 1 Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Transforming Growth Factor Beta 1 Sales Market Share by Application (2021-2032)
  9. 6.3 Global Transforming Growth Factor Beta 1 Price by Application
7 Company Profiles
  1. 7.1 Roche
  2. 7.1.1 Roche Company Information
  3. 7.1.2 Roche Business Overview
  4. 7.1.3 Roche Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Roche Transforming Growth Factor Beta 1 Product Portfolio
  6. 7.1.5 Roche Recent Developments
  7. 7.2 Shionogi Ltd
  8. 7.2.1 Shionogi Ltd Company Information
  9. 7.2.2 Shionogi Ltd Business Overview
  10. 7.2.3 Shionogi Ltd Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Shionogi Ltd Transforming Growth Factor Beta 1 Product Portfolio
  12. 7.2.5 Shionogi Ltd Recent Developments
  13. 7.3 Acceleron Pharma Inc
  14. 7.3.1 Acceleron Pharma Inc Company Information
  15. 7.3.2 Acceleron Pharma Inc Business Overview
  16. 7.3.3 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Product Portfolio
  18. 7.3.5 Acceleron Pharma Inc Recent Developments
  19. 7.4 Genzyme Corp
  20. 7.4.1 Genzyme Corp Company Information
  21. 7.4.2 Genzyme Corp Business Overview
  22. 7.4.3 Genzyme Corp Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Genzyme Corp Transforming Growth Factor Beta 1 Product Portfolio
  24. 7.4.5 Genzyme Corp Recent Developments
  25. 7.5 Isarna Therapeutics GmbH
  26. 7.5.1 Isarna Therapeutics GmbH Company Information
  27. 7.5.2 Isarna Therapeutics GmbH Business Overview
  28. 7.5.3 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Product Portfolio
  30. 7.5.5 Isarna Therapeutics GmbH Recent Developments
  31. 7.6 Scholar Rock
  32. 7.6.1 Scholar Rock Company Information
  33. 7.6.2 Scholar Rock Business Overview
  34. 7.6.3 Scholar Rock Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Scholar Rock Transforming Growth Factor Beta 1 Product Portfolio
  36. 7.6.5 Scholar Rock Recent Developments
  37. 7.7 Sirnaomics Inc
  38. 7.7.1 Sirnaomics Inc Company Information
  39. 7.7.2 Sirnaomics Inc Business Overview
  40. 7.7.3 Sirnaomics Inc Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Sirnaomics Inc Transforming Growth Factor Beta 1 Product Portfolio
  42. 7.7.5 Sirnaomics Inc Recent Developments
  43. 7.8 Eli Lilly and Co
  44. 7.8.1 Eli Lilly and Co Company Information
  45. 7.8.2 Eli Lilly and Co Business Overview
  46. 7.8.3 Eli Lilly and Co Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Eli Lilly and Co Transforming Growth Factor Beta 1 Product Portfolio
  48. 7.8.5 Eli Lilly and Co Recent Developments
  49. 7.9 Formation Biologics Inc
  50. 7.9.1 Formation Biologics Inc Company Information
  51. 7.9.2 Formation Biologics Inc Business Overview
  52. 7.9.3 Formation Biologics Inc Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Formation Biologics Inc Transforming Growth Factor Beta 1 Product Portfolio
  54. 7.9.5 Formation Biologics Inc Recent Developments
  55. 7.10 Novartis AG
  56. 7.10.1 Novartis AG Company Information
  57. 7.10.2 Novartis AG Business Overview
  58. 7.10.3 Novartis AG Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Novartis AG Transforming Growth Factor Beta 1 Product Portfolio
  60. 7.10.5 Novartis AG Recent Developments
8 North America
  1. 8.1 North America Transforming Growth Factor Beta 1 Market Size by Type
  2. 8.1.1 North America Transforming Growth Factor Beta 1 Revenue by Type (2021-2032)
  3. 8.1.2 North America Transforming Growth Factor Beta 1 Sales by Type (2021-2032)
  4. 8.1.3 North America Transforming Growth Factor Beta 1 Price by Type (2021-2032)
  5. 8.2 North America Transforming Growth Factor Beta 1 Market Size by Application
  6. 8.2.1 North America Transforming Growth Factor Beta 1 Revenue by Application (2021-2032)
  7. 8.2.2 North America Transforming Growth Factor Beta 1 Sales by Application (2021-2032)
  8. 8.2.3 North America Transforming Growth Factor Beta 1 Price by Application (2021-2032)
  9. 8.3 North America Transforming Growth Factor Beta 1 Market Size by Country
  10. 8.3.1 North America Transforming Growth Factor Beta 1 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Transforming Growth Factor Beta 1 Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Transforming Growth Factor Beta 1 Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Transforming Growth Factor Beta 1 Market Size by Type
  2. 9.1.1 Europe Transforming Growth Factor Beta 1 Revenue by Type (2021-2032)
  3. 9.1.2 Europe Transforming Growth Factor Beta 1 Sales by Type (2021-2032)
  4. 9.1.3 Europe Transforming Growth Factor Beta 1 Price by Type (2021-2032)
  5. 9.2 Europe Transforming Growth Factor Beta 1 Market Size by Application
  6. 9.2.1 Europe Transforming Growth Factor Beta 1 Revenue by Application (2021-2032)
  7. 9.2.2 Europe Transforming Growth Factor Beta 1 Sales by Application (2021-2032)
  8. 9.2.3 Europe Transforming Growth Factor Beta 1 Price by Application (2021-2032)
  9. 9.3 Europe Transforming Growth Factor Beta 1 Market Size by Country
  10. 9.3.1 Europe Transforming Growth Factor Beta 1 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Transforming Growth Factor Beta 1 Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Transforming Growth Factor Beta 1 Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Transforming Growth Factor Beta 1 Market Size by Type
  2. 10.1.1 China Transforming Growth Factor Beta 1 Revenue by Type (2021-2032)
  3. 10.1.2 China Transforming Growth Factor Beta 1 Sales by Type (2021-2032)
  4. 10.1.3 China Transforming Growth Factor Beta 1 Price by Type (2021-2032)
  5. 10.2 China Transforming Growth Factor Beta 1 Market Size by Application
  6. 10.2.1 China Transforming Growth Factor Beta 1 Revenue by Application (2021-2032)
  7. 10.2.2 China Transforming Growth Factor Beta 1 Sales by Application (2021-2032)
  8. 10.2.3 China Transforming Growth Factor Beta 1 Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Transforming Growth Factor Beta 1 Market Size by Type
  2. 11.1.1 Asia Transforming Growth Factor Beta 1 Revenue by Type (2021-2032)
  3. 11.1.2 Asia Transforming Growth Factor Beta 1 Sales by Type (2021-2032)
  4. 11.1.3 Asia Transforming Growth Factor Beta 1 Price by Type (2021-2032)
  5. 11.2 Asia Transforming Growth Factor Beta 1 Market Size by Application
  6. 11.2.1 Asia Transforming Growth Factor Beta 1 Revenue by Application (2021-2032)
  7. 11.2.2 Asia Transforming Growth Factor Beta 1 Sales by Application (2021-2032)
  8. 11.2.3 Asia Transforming Growth Factor Beta 1 Price by Application (2021-2032)
  9. 11.3 Asia Transforming Growth Factor Beta 1 Market Size by Country
  10. 11.3.1 Asia Transforming Growth Factor Beta 1 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Transforming Growth Factor Beta 1 Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Transforming Growth Factor Beta 1 Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Transforming Growth Factor Beta 1 Market Size by Type
  2. 12.1.1 SAMEA Transforming Growth Factor Beta 1 Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Transforming Growth Factor Beta 1 Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Transforming Growth Factor Beta 1 Price by Type (2021-2032)
  5. 12.2 SAMEA Transforming Growth Factor Beta 1 Market Size by Application
  6. 12.2.1 SAMEA Transforming Growth Factor Beta 1 Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Transforming Growth Factor Beta 1 Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Transforming Growth Factor Beta 1 Price by Application (2021-2032)
  9. 12.3 SAMEA Transforming Growth Factor Beta 1 Market Size by Country
  10. 12.3.1 SAMEA Transforming Growth Factor Beta 1 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Transforming Growth Factor Beta 1 Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Transforming Growth Factor Beta 1 Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Transforming Growth Factor Beta 1 Value Chain Analysis
  2. 13.1.1 Transforming Growth Factor Beta 1 Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Transforming Growth Factor Beta 1 Production Mode & Process
  6. 13.2 Transforming Growth Factor Beta 1 Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Transforming Growth Factor Beta 1 Distributors
  9. 13.2.3 Transforming Growth Factor Beta 1 Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst